| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |